Boston Common Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $17.3M | Buy |
|
|||||
2024
Q4 | $15.5M | Sell |
|
|||||
2024
Q3 | $30.6M | Sell |
|
|||||
2024
Q2 | $34M | Sell |
|
|||||
2024
Q1 | $33.1M | Sell |
|
|||||
2023
Q4 | $37.5M | Sell |
|
|||||
2023
Q3 | $36.6M | Sell |
|
|||||
2023
Q2 | $34.9M | Sell |
|
|||||
2023
Q1 | $42.1M | Sell |
|
|||||
2022
Q4 | $39.2M | Buy |
|
|||||
2022
Q3 | $37.1M | Sell |
|
|||||
2022
Q2 | $35.1M | Buy |
|
|||||
2022
Q1 | $29.8M | Buy |
|
|||||
2021
Q4 | $26.6M | Buy |
|
|||||
2021
Q3 | $25.3M | Buy |
|
|||||
2021
Q2 | $23.2M | Buy |
|
|||||
2021
Q1 | $11.9M | Buy |
|
|||||
2020
Q4 | $5.62M | Buy |
|
|||||
2020
Q3 | $6.21M | Sell |
|
|||||
2020
Q2 | $6.96M | Sell |
|
|||||
2020
Q1 | $5.58M | Sell |
|
|||||
2019
Q4 | $5.96M | Sell |
|
|||||
2019
Q3 | $4.58M | Sell |
|
|||||
2019
Q2 | $5.37M | Buy |
|
|||||
2019
Q1 | $5.28M | Sell |
|
|||||
2018
Q4 | $4.91M | Buy |
|
|||||
2018
Q3 | $4.17M | Sell |
|
|||||
2018
Q2 | $3.97M | Sell |
|
|||||
2018
Q1 | $4.12M | Buy |
|
|||||
2017
Q4 | $4.46M | Buy |
|
|||||
2017
Q3 | $5.18M | Sell |
|
|||||
2017
Q2 | $5.73M | Sell |
|
|||||
2017
Q1 | $5.81M | Buy |
|
|||||
2016
Q4 | $4.29M | Buy |
|
|||||
2016
Q3 | $4.66M | Buy |
|
|||||
2016
Q2 | $3.2M | Buy |
|
|||||
2016
Q1 | $1.73M | Buy |
|